Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00075348 · ClinicalTrials.gov registry record
Genetic Study to Identify Gene Mutations in Participants Previously Enrolled in Clinical Trial NCI-99-C-0053 Who Have Von Hippel-Lindau Syndrome or Are at Risk for Von Hippel-Lindau Syndrome
A clinical trial, sponsored by National Institutes of Health Clinical Center (CC).
- Completed
- Registry status
- 260
- Enrollment target
NCT00075348 is a clinical trial that has completed, run by National Institutes of Health Clinical Center (CC). The registered enrollment target is 260 participants.
The verdict
NCT00075348 has completed, sponsored by National Institutes of Health Clinical Center (CC).
- COMPLETED
- Registry status
- 260 participants
- Enrollment target
Study Summary
RATIONALE: The identification of gene mutations in individuals who have or are at risk for von Hippel-Lindau syndrome may allow doctors to better determine the genetic processes involved in the development of cancer. PURPOSE: This genetic study is finding gene mutations in participants with von Hippel-Lindau syndrome or who are at risk for developing von Hippel-Lindau syndrome.
Interventions
- GENETIC mutation analysis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 260 participants |
| Start Date | 2003-12 |
| Est. Completion | 2008-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00075348
The ClinicalTrials.gov registry entry for NCT00075348 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 260 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is National Institutes of Health Clinical Center (CC), which has 338 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which mutation analysis is the first listed.
NCT00075348 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00075348 about?
NCT00075348 is a clinical study titled "Genetic Study to Identify Gene Mutations in Participants Previously Enrolled in Clinical Trial NCI-99-C-0053 Who Have Von Hippel-Lindau Syndrome or Are at Risk for Von Hippel-Lindau Syndrome". RATIONALE: The identification of gene mutations in individuals who have or are at risk for von Hippel-Lindau syndrome may allow doctors to better determine the genetic processes involved in the development of cancer. PURPOSE: This genetic study is finding gene mutations in participants with von Hip...
What is the current status of trial NCT00075348?
This trial is currently completed. The enrollment target is 260 participants. The study started on 2003-12. Estimated completion is 2008-12.
What interventions are being tested in trial NCT00075348?
The interventions under investigation include: mutation analysis (GENETIC).
Who is sponsoring clinical trial NCT00075348?
This trial is sponsored by National Institutes of Health Clinical Center (CC), which has 338 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.